Status:
RECRUITING
Capella Scientia Development Study
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Brief Summary
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
Detailed Description
In this prospective, noninterventional, single-arm, unmasked, multicenter study, 4 different subject cohorts will be enrolled simultaneously to collect biometry and aberrometry data using Unity DX. Th...
Eligibility Criteria
Inclusion
- Able to understand and sign an IRB/IEC approved consent form;
- Willing and able to attend study visit(s) as required by the protocol;
- Consenting age at the jurisdiction of study site;
- Other group-specific, protocol required inclusion criteria may apply.
Exclusion
- Women of child-bearing potential;
- Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
- Unclear optical media preventing data capture from all devices in the study;
- Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment;
- Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study;
- Other group-specific, protocol required exclusion criteria may apply.
Key Trial Info
Start Date :
July 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06987474
Start Date
July 30 2025
End Date
May 1 2027
Last Update
November 13 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134
2
Narayana Nethralaya
Bangalore, India, 560010
3
Asian Eye Institute
Makati City, Philippines, 1200
4
Clinica Novovision - Clinica Madrid
Madrid, Spain, 28046